Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immuno-senescence”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Testing effectiveness (Phase 2)Study completedNCT00385320
What this trial is testing

Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 2,640
Not applicableActive Not RecruitingNCT06243666
What this trial is testing

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerPersistent Infection
Xiamen University 2,188
Large-scale testing (Phase 3)UnknownNCT04836260
What this trial is testing

Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19

Who this might be right for
Covid19Immuno-DeficiencyOld Age; Debility
University Hospital, Geneva 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05056402
What this trial is testing

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 1,382
Testing effectiveness (Phase 2)Temporarily pausedNCT03312244
What this trial is testing

Pyridostigmine as Immunomodulator in People Living With HIV

Who this might be right for
HIV-1-infectionCD4+ T LymphocytopeniaImmune Deficiency+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 60
Large-scale testing (Phase 3)Study completedNCT00278408
What this trial is testing

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 700
Large-scale testing (Phase 3)Study completedNCT00453986
What this trial is testing

Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,352
Large-scale testing (Phase 3)Study completedNCT01303887
What this trial is testing

A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients

Who this might be right for
Follicular Lymphoma
University of Liverpool 680
Not applicableEnded earlyNCT00926250
What this trial is testing

Effects of PS-IPC Supplementation on Muscle Mass and Functional Outcomes in Older Adults

Who this might be right for
Immune SenescenceSarcopenia
University of Arkansas 18
Large-scale testing (Phase 3)Study completedNCT00343915
What this trial is testing

Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs

Who this might be right for
Hepatitis B
GlaxoSmithKline 267
Large-scale testing (Phase 3)Study completedNCT00731393
What this trial is testing

Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04

Who this might be right for
Influenza
GlaxoSmithKline 157
Large-scale testing (Phase 3)Study completedNCT05433285
What this trial is testing

Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine

Who this might be right for
COVID-19
PT Bio Farma 4,050
Not applicableUnknownNCT04704908
What this trial is testing

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 979
Not applicableStudy completedNCT03206255
What this trial is testing

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 940
Large-scale testing (Phase 3)Study completedNCT04917523
What this trial is testing

Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above

Who this might be right for
COVID-19 PneumoniaCOVID-19
China National Biotec Group Company Limited 1,800
Not applicableStudy completedNCT05465785
What this trial is testing

A Clinical Trial of Immuno-bridging Between Different Manufacture Scales of Recombinant COVID-19 Vaccine (Sf9 Cell)

Who this might be right for
COVID-19SARS-CoV-2 Pneumonia
WestVac Biopharma Co., Ltd. 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06387121
What this trial is testing

Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 53
Large-scale testing (Phase 3)Study completedNCT06551181
What this trial is testing

A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 2,620
Not applicableUnknownNCT05045755
What this trial is testing

The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 1,339
Large-scale testing (Phase 3)Study completedNCT05381350
What this trial is testing

Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 1,750
Load More Results